Hydroxychloroquine
Clinical trials have shown the drug cuts the duration of symptoms, but there's previously been no data on survival.
The top U.S. infectious disease expert, responding to Trump's latest touting of the drug, cites clinical trials that have found it ineffective.
Health officials are unsure what to do with stockpiles of the drug and the related chloroquine after the FDA declared them risky and likely ineffective to treat coronavirus.
WHO’s director-general, Tedros Adhanom Ghebreyesus, said its experts had advised the continuation of all trials including hydroxychloroquine.
WHO chief said its global “Solidarity” trial decided to conduct a comprehensive review of all available data on hydroxychloroquine and that its use in the trial would be suspended for now.
A WHO doctor said Brazil is the most affected country in South America, and is relying heavily on the disputed drug hydroxychloroquine for treatment.
A study spanning six continents, led by Dr. Mandeep Mehra, looked into the safety and benefit of using Hydroxychloroquine for COVID-19 patients
US president tells reporters he has been taking a pill every day for the last week-and-a-half.
The US Food and Drug Administration has lifted a 3 year-long import ban on chloroquine products manufactured by Mumbai-based Ipca Laboratories, a company that it last investigated in August 2019.
A large part of the 29 million doses of hydroxychloroquine bought by the US is from India, President Donald Trump said.